达索系统二季度业绩符合指引并宣布18亿美元收购ArisGlobal

Google raises annual spending estimates amid rapid AI infrastructure build-out
Introduction & Market Context
Dassault Systèmes (EPA:DSY) presented its second quarter 2026 results on July 23, revealing solid financial performance alongside a transformative $1.8 billion acquisition that positions the French software giant as a comprehensive player in life sciences. The company characterized 2026 as a "foundation year" for turning artificial intelligence into concrete industrial value, marking a strategic pivot in its four-decade evolution from 3D design software to what it calls an "AI-native agentic platform."
The presentation confirmed full-year guidance while announcing the acquisition of ArisGlobal, an AI-powered regulatory and safety platform serving the pharmaceutical industry. Shares rose 2.41% to $18.19, reflecting investor approval of the company’s strategic direction despite ongoing challenges in certain markets and product lines.
Quarterly Performance Highlights
Dassault Systèmes reported total revenue of €1,556 million for the second quarter, representing 4% growth on a constant-currency basis. The company’s non-IFRS earnings per share reached €0.31, up 8% year-over-year, demonstrating improved profitability alongside revenue expansion.
The following chart illustrates the company’s performance against its annual objectives:
Operating margin improved to 30.0%, expanding by 90 basis points on a currency-neutral basis. This margin improvement reflected disciplined cost management and productivity gains, even as the company continued investing in AI capabilities and platform development.
Software revenue, which comprises 90% of total revenue, grew 4% to €1,401 million. The recurring portion of software revenue reached 83%, up from the prior year, with subscription revenue growing 8%—twice the pace of overall software sales. Subscription now represents 50% of recurring revenue, marking continued progress in the company’s shift toward more predictable revenue streams.
Strong Momentum in Platform Adoption
The company’s 3DEXPERIENCE platform and cloud offerings demonstrated robust growth, serving as key drivers of the quarter’s performance. As shown in the following breakdown of software revenue growth:
3DEXPERIENCE software revenue grew 14% in the second quarter, with the platform now representing 42% of eligible software revenue, up from 40% in the first half of 2025. Cloud-based 3DEXPERIENCE solutions surged 60%, while overall cloud revenue increased 14% to represent 27% of software revenue.
Annual Run Rate (ARR), a key metric for recurring business health, reached €4,443 million at quarter-end, up 6% year-over-year on a constant-currency basis. The metric increased by €73 million sequentially, as illustrated in the following evolution chart:
ArisGlobal Acquisition: Expanding Life Sciences Leadership
The centerpiece of the presentation was the announcement of Dassault Systèmes’ agreement to acquire ArisGlobal for $1.8 billion, with an additional $200 million in contingent payments tied to multi-year AI-related performance milestones. The acquisition represents a strategic expansion into regulatory, safety, quality, and medical affairs software for the life sciences industry.
ArisGlobal brings approximately $175 million in expected 2026 revenue with double-digit growth rates and operating margins aligned with Dassault Systèmes’ profile. The company serves over 200 customers, including 50% of the top 50 biopharma companies, with a 97%+ gross retention rate demonstrating the mission-critical nature of its platform.
The acquisition’s strategic rationale centers on creating what Dassault Systèmes describes as a unified AI intelligence platform connecting molecules, patients, and real-world outcomes. As detailed in the following platform overview:
ArisGlobal’s AI-native platform processes 25 million industry adverse events annually, with 12 million safety reports recorded each year. The company’s NavaX AI technology has already demonstrated proven efficiency gains exceeding 30% in safety, regulatory, and quality workflows.
The life sciences market opportunity is substantial, with the serviceable addressable market for regulatory, safety, and quality software estimated at $7.5 billion by 2030, approximately 50% of which represents software and AI solutions. As shown in the following market analysis:
Structural tailwinds include increasing therapeutic complexity, heightened regulatory scrutiny requiring continuous real-world data monitoring, and an industry-wide shift converting manual services into scalable software spend through AI-driven automation.
Creating a Unified Intelligence Platform
The ArisGlobal acquisition fits within Dassault Systèmes’ broader strategy to integrate AI capabilities across the entire life sciences value chain. The following diagram illustrates how NavaX integrates with the company’s existing Virtual Companions:
This integration connects research and development (supported by MARIE), clinical development (LOUIS), manufacturing (LEO and AURA), and now regulatory and safety (NavaX) into a single platform that spans from molecular insight to real-world patient outcomes.
The company’s AI strategy extends beyond life sciences. During the quarter, Dassault Systèmes expanded its 3DEXPERIENCE AI-native agentic platform with new Virtual Companion capabilities designed for co-engineering with humans across multiple industries.
Regional and Product Line Performance
Performance varied significantly across geographies in the second quarter. The following regional breakdown shows software revenue distribution and growth:
Asia delivered the strongest performance with 8% growth, driven by excellent results in India, Korea, and Japan. China was lower year-over-year, though management noted improving pipeline visibility for the second half. The Americas grew 5%, supported by strength in Home & Lifestyle, High Tech, and Industrial Equipment sectors.
Europe was flat in the quarter after strong first-quarter growth, reflecting continued weakness in the automotive sector in mainland Europe. This was partially offset by double-digit growth in Northern Europe. Energy, Industrial Equipment, and Aerospace & Defense showed healthy growth despite automotive headwinds.
By product line, Industrial Innovation software grew 5%, driven by strong 3DEXPERIENCE and cloud adoption, with CATIA, ENOVIA, and DELMIA leading the momentum. Mainstream Innovation surged 8%, with SOLIDWORKS showing broad-based geographic momentum and CENTRIC strengthening beyond its traditional apparel focus.
Life Sciences revenue declined 4%, with MEDIDATA down 3%. However, management highlighted that solid first-half bookings are driving ARR growth, suggesting improving momentum ahead.
Customer Success Stories Demonstrate Tangible Value
The presentation featured multiple customer case studies illustrating how the company’s AI-driven Virtual Twin technology delivers measurable business outcomes. Mahindra & Mahindra, the Indian automotive manufacturer, expanded to 6,500 users on the 3DEXPERIENCE cloud platform, achieving reduced cycle times and AI-enabled workflows across its partner network:
In the semiconductor industry, a leading memory manufacturer deployed the platform for full digital continuity from design to consumer, achieving faster time to market through Virtual Twin validation:
The consumer goods sector also demonstrated strong adoption. Polyconcept North America optimized the lifecycle of personalized goods using Centric’s AI-powered platform, achieving operational simplification and faster product development:
Perhaps most compelling was a customer example showing the 3DEXPERIENCE Agentic Platform’s ability to deliver concrete value through AI-driven design exploration. As illustrated in the following comparison:
BMW used the platform for parametric design studies, evaluating 48 variants in a single setup with 96% accuracy—a dramatic improvement from traditional approaches where engineers "picked one variant and hoped." More advanced applications achieved 100 variants with over 84% accuracy, while the full agentic platform enabled exploration of thousands of variants with 100% accuracy and traceability.
Financial Position and Cash Generation
Dassault Systèmes demonstrated strong cash generation in the first half of 2026. Operating cash flow reached €1,237 million, up 8% year-over-year on a reported basis and 11% on a constant-currency basis. Free cash flow totaled €1,113 million, and cash conversion improved to 134% compared to 123% in the prior year.
The company’s balance sheet remains robust with €5.7 billion in cash and cash equivalents as of June 30, 2026, an increase of €1,535 million from year-end 2025. This strong position enabled the company to fund the ArisGlobal acquisition entirely from existing cash while maintaining substantial balance sheet flexibility.
Financial debt stood at €3,378 million, resulting in a net cash position of €2,282 million. The company issued bonds during the period to optimize its capital structure while maintaining financial flexibility for future investments.
Strategic Evolution: From Industry to Metamorphosis
The presentation positioned 2026 as a pivotal year in Dassault Systèmes’ evolution, marking what the company calls the "Metamorphosis" phase of its development. This represents the fourth major stage following Industry (1981-1999), Experience (1999-2020), and Human (2020-2026) phases.
The company’s strategic framework centers on three pillars: transforming existing clients by turning industry headwinds into advantages through 3DEXPERIENCE and cloud adoption; conquering new frontiers in Life Sciences and Consumer industries while expanding within existing clients; and expanding "3D UNIVERSES" to turn AI into concrete value.
CEO Pascal Daloz emphasized this transformation in the earnings call, stating that 2026 will be "the foundation year" and that the company is building "for much more." He noted that customers are no longer asking whether AI will reshape engineering and manufacturing, but how fast they can deploy it.
Outlook and Guidance
Dassault Systèmes confirmed its full-year 2026 financial objectives despite ongoing challenges in certain markets. The company expects total revenue of €6,296 million to €6,416 million, representing 3% to 5% growth on a constant-currency basis. Operating margin is projected at 32.2% to 32.6%, with earnings per share of €1.30 to €1.34, up 3% to 6%.
For the third quarter, the company projected revenue of €1,497 million to €1,537 million, up 3% to 5% on a constant-currency basis, with EPS of €0.30 to €0.31 and operating margin of 31.0% to 31.1%.
Management outlined three priorities for the remainder of the year: helping customers migrate to the cloud, expanding in new industries such as life sciences and high tech, and continuing to build the agentic AI platform. The ArisGlobal acquisition is expected to close in late third quarter or early fourth quarter and should be accretive to both revenue growth and EPS in the first year following closing.
CFO Rouven Bergmann emphasized the company’s ability to balance growth with discipline, stating, "This Q2 performance keeps us firmly on track for the full year," while noting improvements in cash flow and margins alongside new AI product category launches.
Risks and Considerations
Despite the positive results and strategic announcements, several challenges merit attention. Regional performance remains uneven, with Europe flat and China down, indicating growth is not yet broad-based. The automotive sector, particularly in mainland Europe, continues facing difficult industry conditions.
The Medidata business within Life Sciences showed a 3% revenue decline, though management expressed confidence in improving trends based on bookings momentum. The integration of ArisGlobal, while strategically compelling, will require careful execution to realize anticipated synergies and maintain the acquired company’s customer relationships and growth trajectory.
The company’s heavy investment in AI capabilities represents both opportunity and execution risk. While customer examples demonstrate tangible value, investors will monitor whether the AI platform expansion translates into sustained revenue acceleration and market share gains across the company’s diverse industry verticals.
Currency volatility also remains a consideration, with the company’s significant exposure to the U.S. dollar and Japanese yen creating earnings variability. The presentation assumed exchange rates of $1.18 per euro and JPY 170.0 per euro for third-quarter guidance, with full-year assumptions of $1.17 per euro and JPY 177.1 per euro.
Nevertheless, the combination of solid second-quarter execution, strategic expansion into life sciences through ArisGlobal, and advancing AI capabilities positions Dassault Systèmes for what management characterizes as a transformative period in its evolution from traditional CAD software provider to comprehensive industrial intelligence platform.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.